| 摘要 |
<p>The invention relates to novel compounds having the general formula: (I) and are useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis, cardiovascular disease, rheumatoid arthritis or prostate cancer.</p> |
